Works by Oberdhan, Dorothee

Results: 18

FP046 A PHASE 2 DOSE-RANGING STUDY COMPARING PHARMACOKINETICS (PK), PHARMACODYNAMICS (PD), AND TOLERABILITY OF MODIFIED RELEASE (MR) VS IMMEDIATE RELEASE (IR) TOLVAPTAN (TLV) IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS (PT).

Published in:

Nephrology Dialysis Transplantation, 2019, v. 34, p. N.PAG, doi. 10.1093/ndt/gfz106.FP046

By:

Perrone, Ronald;
Chapman, Arlene;
Oberdhan, Dorothee;
Czerwiec, Frank S;
Sergeyeva, Olga;
Ouyang, John;
Shoaf, Susan

Publication type:

Article

FP045 NOCTURNE: A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO COMPARE TOLVAPTAN (TLV) MODIFIED-RELEASE (MR) AND IMMEDIATE-RELEASE (IR) FORMULATIONS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS (PT).

Published in:

Nephrology Dialysis Transplantation, 2019, v. 34, p. N.PAG, doi. 10.1093/ndt/gfz106.FP045

By:

Perrone, Ronald;
Chapman, Arlene;
Oberdhan, Dorothee;
Czerwiec, Frank S;
Sergeyeva, Olga;
Ouyang, John;
Shoaf, Susan

Publication type:

Article

Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage.

Published in:

Journal of Medical Economics, 2021, v. 24, p. 93, doi. 10.1080/13696998.2021.1877146

By:

Gagnon-Sanschagrin, Patrick;
Liang, Yawen;
Sanon, Myrlene;
Oberdhan, Dorothee;
Guérin, Annie;
Cloutier, Martin

Publication type:

Article

Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage.

Published in:

Journal of Medical Economics, 2021, v. 24, n. 1, p. 193, doi. 10.1080/13696998.2021.1877146

By:

Gagnon-Sanschagrin, Patrick;
Liang, Yawen;
Sanon, Myrlene;
Oberdhan, Dorothee;
Guérin, Annie;
Cloutier, Martin

Publication type:

Article

Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease.

Published in:

Neurology & Therapy, 2023, v. 12, n. 2, p. 571, doi. 10.1007/s40120-023-00443-2

By:

DiBenedetti, Dana B.;
Menne, Heather;
Paulsen, Russ;
Krasa, Holly B.;
Vradenburg, George;
Comer, Meryl;
Callahan, Leigh F.;
Winfield, John;
Potashman, Michele;
Heithoff, Kim;
Hartry, Ann;
Oberdhan, Dorothee;
Wilson, Hilary;
Hoffman, Deborah L.;
Wieberg, Dan;
Kremer, Ian N.;
Taylor, Geraldine A.;
Taylor, James M.;
Lappin, Debra;
Martin, Allison D.

Publication type:

Article

Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study.

Published in:

International Journal of Nephrology & Renovascular Disease, 2021, v. 14, p. 105, doi. 10.2147/IJNRD.S297491

By:

Aigbogun, Myrlene Sanon;
Oberdhan, Dorothee;
Doane, Michael J;
Rooney, Jillian;
Inyart, Brian C;
Pao, Christina S;
Denny, Alexis H

Publication type:

Article

Effects of tolvaptan discontinuation in patients with autosomal dominant polycystic kidney disease: a post hoc pooled analysis.

Published in:

BMC Nephrology, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12882-023-03247-6

By:

Lioudis, Michael;
Zhou, Xiaolei;
Davenport, Eric;
Nunna, Sasikiran;
Krasa, Holly B.;
Oberdhan, Dorothee;
Fernandes, Ancilla W.

Publication type:

Article

A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney disease.

Published in:

2022

By:

Mader, Gregory;
Mladsi, Deirdre;
Sanon, Myrlene;
Purser, Molly;
Barnett, Christine L.;
Oberdhan, Dorothee;
Watnick, Terry;
Seliger, Stephen

Publication type:

journal article

Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease.

Published in:

Kidney International, 2013, v. 84, n. 6, p. 1278, doi. 10.1038/ki.2013.285

By:

Boertien, Wendy E;
Meijer, Esther;
de Jong, Paul E;
Bakker, Stephan J L;
Czerwiec, Frank S;
Struck, Joachim;
Oberdhan, Dorothee;
Shoaf, Susan E;
Krasa, Holly B;
Gansevoort, Ron T

Publication type:

Article

Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer's Disease Interventions.

Published in:

2019

By:

Lin, Pei-Jung;
D'Cruz, Brittany;
Leech, Ashley A.;
Neumann, Peter J.;
Sanon Aigbogun, Myrlene;
Oberdhan, Dorothee;
Lavelle, Tara A.

Publication type:

journal article

FAMILY AND CAREGIVER SPILLOVER EFFECTS IN ALZHEIMER’S DISEASE COST-EFFECTIVENESS ANALYSES.

Published in:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1565, doi. 10.1016/j.jalz.2017.07.720

By:

Lin, Pei-Jung;
D’Cruz, Brittany;
Leech, Ashley;
Neumann, Peter J.;
Aigbogun, Myrlene Sanon;
Oberdhan, Dorothee;
Lavelle, Tara

Publication type:

Article

Care partner evaluation of the behaviors in the Cohen-Mansfield Agitation Inventory.

Published in:

Frontiers in Dementia, 2024, p. 1, doi. 10.3389/frdem.2024.1328874

By:

Oberdhan, Dorothee;
Palsgrove, Andrew;
Houle, Christy;
Lovell, Teya;
Levine, A. Alex;
Frangiosa, Terry;
Biggar, Ginny;
Comer, Meryl

Publication type:

Article

Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data.

Published in:

ClinicoEconomics & Outcomes Research, 2015, v. 7, p. 123, doi. 10.2147/CEOR.S75523

By:

Knight, Tyler;
Schaefer, Caroline;
Krasa, Holly;
Oberdhan, Dorothee;
Chapman, Arlene;
Perrone, Ronald D.

Publication type:

Article

Defining a clinically meaningful within-patient change threshold for the Cohen-Mansfield Agitation Inventory in Alzheimer's dementia.

Published in:

Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1379062

By:

Meunier, Juliette;
Creel, Kristin;
Loubert, Angély;
Larsen, Klaus Groes;
Aggarwal, Jyoti;
Hefting, Nanco;
Oberdhan, Dorothee

Publication type:

Article

Understanding Patients' Experiences with Borderline Personality Disorder: Qualitative Interviews.

Published in:

Neuropsychiatric Disease & Treatment, 2023, v. 19, p. 2115, doi. 10.2147/NDT.S423882

By:

DiBenedetti, Dana;
Kosa, Katherine;
Waters, Heidi C;
Oberdhan, Dorothee

Publication type:

Article

Developing a Conceptual Disease Model of Patient Experiences and Identifying Patient-Reported Clinical Outcome Assessments for Use in Trials of Treatments for Focal Onset Seizures.

Published in:

Neuropsychiatric Disease & Treatment, 2022, v. 18, p. 611, doi. 10.2147/NDT.S354031

By:

Oberdhan, Dorothee;
Bacci, Elizabeth;
Hill, Jennifer N;
Palsgrove, Andrew;
Hareendran, Asha

Publication type:

Article

Review of Clinical Outcome Assessments in Pediatric Attention-Deficit/Hyperactivity Disorder.

Published in:

Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 1619, doi. 10.2147/NDT.S248685

By:

Markowitz, Jessica T;
Oberdhan, Dorothee;
Ciesluk, Anna;
Rams, Alissa;
Wigal, Sharon B

Publication type:

Article

The societal economic burden of autosomal dominant polycystic kidney disease in the United States.

Published in:

2020

By:

Cloutier, Martin;
Manceur, Ameur M.;
Guerin, Annie;
Aigbogun, Myrlene Sanon;
Oberdhan, Dorothee;
Gauthier-Loiselle, Marjolaine

Publication type:

journal article